Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study
- PMID: 16234515
- DOI: 10.1200/JCO.2004.00.7138
Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study
Abstract
Purpose: The purpose of this study was to estimate the extent of protection offered against breast cancer by prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations and to determine to what extent risk reduction varies with age at oophorectomy, age at diagnosis, and time elapsed since surgery.
Patients and methods: We analyzed 1,439 patients with breast cancer and 1,866 matched controls derived from a registry of BRCA1 and BRCA2 carriers. We estimated odds ratios (ORs) of breast cancer for having had a bilateral oophorectomy, using conditional logistic regression, matched for parity and for oral contraceptive use.
Results: A previous history of oophorectomy was associated with a significant reduction in breast cancer risk of 56% for BRCA1 carriers (OR = 0.44; 95% CI, 0.29 to 0.66) and of 46% for BRCA2 carriers (OR = 0.57; 95% CI, 0.28 to 1.15). The risk reduction was greater if the oophorectomy was performed before age 40 (OR = 0.36; 95% CI, 0.20 to 0.64 for BRCA1 carriers) than after age 40 (OR = 0.53; 95% CI, 0.30 to 0.91). The protective effect was evident for 15 years post-oophorectomy (OR = 0.39; 95% CI, 0.26 to 0.57).
Conclusion: Oophorectomy is an effective means of reducing the risk of breast cancer in carriers of BRCA1 mutations. The data suggest oophorectomy is protective in BRCA2 carriers as well, but needs to be confirmed in other studies.
Similar articles
-
Changes in body weight and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.Breast Cancer Res. 2005;7(5):R833-43. doi: 10.1186/bcr1293. Epub 2005 Aug 19. Breast Cancer Res. 2005. PMID: 16168130 Free PMC article.
-
Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.Gynecol Oncol. 2005 May;97(2):457-67. doi: 10.1016/j.ygyno.2005.01.039. Gynecol Oncol. 2005. PMID: 15863145
-
Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.Clin Cancer Res. 2002 Dec;8(12):3776-81. Clin Cancer Res. 2002. PMID: 12473589
-
Family history as a predictor of uptake of cancer preventive procedures by women with a BRCA1 or BRCA2 mutation.Clin Genet. 2008 May;73(5):474-9. doi: 10.1111/j.1399-0004.2008.00988.x. Epub 2008 Mar 12. Clin Genet. 2008. PMID: 18341607 Review.
-
[Genetic test and prophylactic treatment in breast cancer families].Gan To Kagaku Ryoho. 2002 Apr;29(4):512-22. Gan To Kagaku Ryoho. 2002. PMID: 11977534 Review. Japanese.
Cited by 111 articles
-
Implementation and evaluation of a nurse-led decision-coaching program for healthy breast cancer susceptibility gene (BRCA1/2) mutation carriers: a study protocol for the randomized controlled EDCP-BRCA study.Trials. 2020 Jun 8;21(1):501. doi: 10.1186/s13063-020-04431-x. Trials. 2020. PMID: 32513307 Free PMC article.
-
Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers.Breast Cancer Res. 2020 Jan 16;22(1):8. doi: 10.1186/s13058-020-1247-4. Breast Cancer Res. 2020. PMID: 31948486 Free PMC article.
-
Contralateral Breast Cancer and Ipsilateral Breast Tumor Recurrence in BRCA1/2 Carriers and Non-Carriers at High-Risk of Hereditary Breast Cancer.J Breast Cancer. 2019 Sep 30;22(4):587-598. doi: 10.4048/jbc.2019.22.e47. eCollection 2019 Dec. J Breast Cancer. 2019. PMID: 31897332 Free PMC article.
-
Countercurrents: The bias of choice.Curr Oncol. 2019 Dec;26(6):e712-e713. doi: 10.3747/co.26.5165. Epub 2019 Dec 1. Curr Oncol. 2019. PMID: 31896940 Free PMC article. No abstract available.
-
BRCA testing in unaffected young women in the United States, 2006-2017.Cancer. 2020 Jan 15;126(2):337-343. doi: 10.1002/cncr.32536. Epub 2019 Sep 30. Cancer. 2020. PMID: 31568561
Publication types
MeSH terms
Substances
Grant support
LinkOut - more resources
-
Full Text Sources
-
Medical
-
Research Materials
-
Miscellaneous